PCV48 - TOTAL ANNUAL HEALTHCARE COSTS OF HEART FAILURE BETWEEN 2005 AND 2014: A RETROSPECTIVE, POPULATION-BASED STUDY IN SWEDEN
Kurt Boman(Umeå University), Gerhard Wikström(Uppsala University), Madlaina Costa‐Scharplatz(Novartis (Sweden)), Sara Bruce Wirta(Novartis (Switzerland)), Mona Olofsson(Skellefteå Hospital), Anna Castelo‐Branco, Krister Lindmark(Umeå University), Michael Törnblom, Ana Filipa Fonseca(Allgemeine Gewerbeschule Basel), Jan Stålhammar(Uppsala University)
Cited by 1
Related Papers
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
|New England Journal of Medicine|2008|1.6k
In Vivo Visualization of Amyloid Deposits in the Heart with <sup>11</sup>C-PIB and PET
|Journal of Nuclear Medicine|2012|258
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
|Journal of Cardiovascular Pharmacology|2020|111
Organization of Heart Failure Management in European Society of Cardiology Member Countries: Survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups
|European Journal of Heart Failure|2013|83
Can a sustainable community intervention reduce the health gap? -10-Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease
|Scandinavian Journal of Public Health|2001|82